Startups
Abzu
Abzu ApS (Danish CVR39248530) was a Copenhagen/Barcelona artificial-intelligence and biotechnology company. Its proprietary QLattice produced interpretable models for scientific data, biomarker discovery and RNA drug design, including experimental siRNA and antisense oligonucleotide work. Its published research and Contera Pharma collaboration addressed disease understanding and therapeutic design; these are research capabilities, not clinical approval or demonstrated patient efficacy. The Danish Maritime and Commercial Court placed the exact Danish company into bankruptcy proceedings by decree on April15,2026, case K805/26-K, following an April9 petition; official notice S15042026-470 identifies the company and CVR. Its own LinkedIn profile now says it no longer exists. The company website fails TLS retrieval, while cached own pages preserve the last nine-person roster, dated February2026. All roster roles are therefore explicitly historical; no current operating team is claimed. Victor Galindo succeeded Casper Wilstrup as CEO in May2024. Own brand history confirms a EUR5.8M seed financing in April2021; the exact full closing day remains unpublished in the primary evidence reviewed. Cumulative VC/total-funding figures and the EUR2.5M EIC grant award are not additional executed cash rounds. Former investors and current-at-publication PSV backing are distinguished; shareholder percentages are not individual cash checks. Additional primary history: co-founder Kevin Broløs’s October15,2019 public post reproduces Abzu’s explicit announcement of another EUR1.75M raised. This incremental financing is recorded separately with its exact cash closing day, stage and undisclosed subscribers left unknown; the co-founder’s repost date is not a financing close.
Founded 2018
Team
 Casper WilstrupCo-founder, former Chief Executive Officer and historical Adviser |
Christine Søholm HansenBioinformatician — historical February 2026 roster |
Disa TehlerHead of RNA Therapeutics — former, February 2026 roster |
Jim ShurSoftware Developer — historical February 2026 roster |
Kasper SommerChief Financial Officer — historical February 2026 roster |
 Kevin BroløsCo-founder and Mad Scientist — historical February 2026 roster |
Maria JacobsenOperations and Administration Lead — historical February 2026 roster |
Martin KerrBusiness Development and Pharma Partnerships — historical February 2026 roster |
Meera MachadoData Person and Physicist — historical February 2026 roster |
Victor Galindo BataneroCo-founder and Chief Executive Officer — former |